SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Denis Chem Lab Ltd (537536)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 537536 NSE: Pharmaceuticals & Drugs | Small Cap | Denis Chem Lab Share Price

₹73.65 0.04 (0.05%)

As on 02-Jul'26 16:59

Denis Chem Lab Ltd (537536)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 537536 NSE: Pharmaceuticals & Drugs | Small Cap | Denis Chem Lab Share Price

₹73.65 0.04 (0.05%)

As on 02-Jul'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹102 Cr.
Current Price
₹73.7
52-Week Low / High
₹56 / 105
TTM EPS
₹6.1
TTM Sales
₹182 Cr.
Book Value per Share
₹66
P/E Ratio
12.16
Lower than its 5-year historical median
Industry PE
49.2
Price to Book (P/B)
1.12
Lower than its 5-year historical median
Price to Sales (P/S)
0.56
Lower than its 5-year historical median
EV/EBITDA
3.95
Lower than its 5-year historical median
Dividend Yield
2.04%
Profitability Efficiency
Return on Equity (ROE)
9.76%
Outperforms industry median
Return on Capital Employed (ROCE)
13.89%
Outperforms industry median
Return on Assets (ROA)
7.29%
Operating Profit Margin
9.3%
Net Profit Margin
4.66%
Gross Profit Margin
10.4%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
3.27%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-24.12%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-27.6%
Asset Quality
Promoter Holding
38.98%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹78 Cr.
Equity
₹13.9 Cr.
Face Value
₹10
All Time Low / High
₹16.26 / 232.90

Denis Chem Lab stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Somewhat Good

Valuation

Somewhat Undervalued

Price Trend

Weak
Q.1 Is Denis Chem Lab Ltd a good quality company?
Denis Chem Lab Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Denis Chem Lab Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Denis Chem Lab Ltd vs industry peers?
Denis Chem Lab Ltd revenue CAGR is 4.94%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Denis Chem Lab Ltd?
Promoters hold 38.98% of the Denis Chem Lab Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Denis Chem Lab Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -2.2% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Denis Chem Lab Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 5.3%12.2%9.4%11.9%11.3%6.5%13.8%16.1%20.2%13.9%-
Value Creation
Index
-0.6-0.1-0.3-0.2-0.2-0.50.00.20.40.0-

Growth Parameters

Sales 99.6113107124136109137161168173182
Sales YoY Gr.-13.8%-5.4%15.8%9.7%-19.7%24.9%17.8%4.3%3.3%-
Adj EPS -4.70.91.64.131.64.55.785.86.1
YoY Gr.-NA80.2%149.4%-25.9%-45.9%174.4%25.8%42.1%-27.7%-
BVPS (₹) 1324.13640.742.644.347.952.157.961.366
Adj Net
Profit
-4.51.12.35.74.22.36.37.911.28.18
Cash Flow from Ops. 20.96.810.6813.4817.116.317.812.1-
Debt/CF from Ops. 2.15.52.42.911.10.20.10.10.1-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 6.3%4.9%8.3%3.3%
Adj EPS NA13.9%8.9%-27.7%
BVPS18.8%7.6%8.6%5.9%
Share Price -0.8% 7.1% -6.5% -26.6%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-274.95.710.77.33.89.811.314.69.89.5
Op. Profit
Mgn %
8.512.311.411.2119.410.511.712.79.39.7
Net Profit
Mgn %
-4.512.14.63.12.14.64.96.74.74.6
Debt to
Equity
3.51.30.50.40.20.10.10000
Working Cap
Days
122114146139131157123103999881
Cash Conv.
Cycle
4624365366805944403749

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales100113107124136109137161168173
Operating Expenses + 91999511012199122142147157
Manufacturing Costs8101011141012151515
Material Costs52534961625572848796
Employee Cost 913912121112131415
Other Costs 21242725332326293031
Operating Profit 8141214151014192116
Operating Profit Margin (%) 8.5%12.3%11.2%11.2%11.0%9.4%10.5%11.7%12.7%9.3%
Other Income + 0112001112
Exceptional Items 0000000000
Interest 7653321111
Depreciation 6766766877
Profit Before Tax -3226639111511
Tax 11-0-0213343
Profit After Tax -41264268118
PAT Margin (%) -4.5%1.1%2.0%5.1%3.1%2.1%4.6%4.9%6.7%4.7%
Adjusted EPS (₹)-4.71.01.54.63.01.64.55.78.05.8
Dividend Payout Ratio (%)0%0%0%21.90%0%46%33.20%35.30%31.10%25.80%

Valuation of Denis Chem Lab - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 12305056596266728085
Share Capital 9121414141414141414
Reserves 3183643454853586671
Debt +363321191182111
Long Term Debt201795242100
Short Term Debt16161314850000
Minority Interest0000000000
Trade Payables17202017181620182121
Others Liabilities 191110131078875
Total Liabilities 859410110697929699109112

Fixed Assets

Net Fixed Assets +40444050464142353839
Gross Block627475929495101102111119
Accumulated Depreciation22293541485459677481
CWIP 10150000200
Investments 0000000000
Inventories6578991091010
Trade Receivables23323136353332313231
Cash Equivalents 37116459172526
Others Assets 4575444557
Total Assets 859410110697929699109112

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 21711813817161812
PBT -3226639111511
Adjustment 1312108976866
Changes in Working Capital 12-7-1-50-23-010
Tax Paid 0-0-0-1-2-1-1-2-4-5
Cash Flow From Investing Activity + -13-1-16-2-2-1-10-11-15-8
Capex -13-2-8-9-2-2-5-5-7-8
Net Investments 01-86-00-5-7-9-1
Others -0000000011
Cash Flow From Financing Activity + -7-01-5-14-6-7-4-4-4
Net Proceeds from Shares 016180000000
Net Proceeds from Borrowing -4-7-12-4-3-0-1-1-00
Interest Paid -7-6-5-3-3-2-1-1-1-1
Dividend Paid -0000-20-1-2-3-3
Others 4-4-02-6-4-4-0-0-0
Net Cash Flow 15-41-31-01-1-0

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-30.415.865.3711.947.293.769.7911.3314.629.76
ROCE (%)5.312.199.3711.911.346.513.7916.0720.1513.89
Asset Turnover Ratio1.251.321.111.21.341.151.451.641.611.56
PAT to CFO Conversion(x)N/A75.51.333.2542.8321.641.5
Working Capital Days
Receivable Days84.5084.30105.6098.1095.10113.3086.5071.6068.4065.60
Inventory Days16.7016.5020.7022.8022.7029.5025.4021.602121.10
Payable Days87.80126.10150.10111.40104.70111.7089.2082.1083.4081.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Denis Chem Lab Ltd FAQs

The current trading price of Denis Chem Lab on 02-Jul-2026 16:59 is ₹73.65.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Denis Chem Lab stood at ₹102.2 Cr

The latest P/E ratio of Denis Chem Lab as of 01-Jul-2026 is 12.16.

The latest P/B ratio of Denis Chem Lab as of 01-Jul-2026 is 1.12.

The 52-week high of Denis Chem Lab is ₹104.8 and the 52-week low is ₹56.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Denis Chem Lab is ₹182 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Denis Chem Lab Ltd is a average quality company.

The key valuation ratios of Denis Chem Lab Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Denis Chem Lab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Denis Chem Lab Ltd

Denis Chem Lab is a Public Limited Pharmaceutical Company incorporated in 1982. It started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years it has been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. It Manufactures and market sterile Intravenous injectibles in Both Glass and Plastic Bottles.

The company’s manufacturing facilities are located in a pollution free environment near Ahmedabad, Gujarat. The Manufacturing facilities are located on a land area of about 14000 sq. metres, the built up area for the manufacturing operations is about 7000 sq.m.

Its manufacturing facilities have been approved by the Foods and Drugs Control Administration Authority (FDCA), Gujarat & WHO GMP. It has also been approved by international bodies, includes FDCA Ivory Cost, Ministry of Health-Vietnam, Ministry of Health-Combodia.

Business area of the company

The company is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles. It offers wide range of sterile intravenous injectables for human and veterinary consumption. The company’s product offerings comprise of various products sold across several states in India. It also exports sterile intravenous medicines to countries like Sri Lanka, Nepal, Combodia, Vietnam, Somalia, Ivory Cost etc. In addition to manufacturing its own products which it sells under its own brands, it does manufacture products on contract basis for third parties including certain multinational pharmaceutical companies who market such products under their own brands.

You have 3 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: